Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression
Authors
Keywords
Bile acids, Fibrosis, Metabolomics, NAFLD, NASH
Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 116, Issue -, Pages 154457
Publisher
Elsevier BV
Online
2020-12-02
DOI
10.1016/j.metabol.2020.154457
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The association of serum total bile acid with non-alcoholic fatty liver disease in Chinese adults: a cross sectional study
- (2020) Ziyu Zhang et al. Lipids in Health and Disease
- Obeticholic acid for the treatment of NASH
- (2020) Jordan Hindson Nature Reviews Gastroenterology & Hepatology
- Obeticholic acid for the treatment of nonalcoholic steatohepatitis
- (2020) Raj A. Shah et al. Expert Review of Gastroenterology & Hepatology
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD
- (2018) Cyrielle Caussy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
- (2018) Brian N. Finck DIABETES
- The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
- (2017) Puneet Puri et al. HEPATOLOGY
- TRIB1 is a positive regulator of hepatocyte nuclear factor 4-alpha
- (2017) Sébastien Soubeyrand et al. Scientific Reports
- Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World
- (2016) Mehmet Sayiner et al. Clinics in Liver Disease
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- Genetics of nonalcoholic fatty liver disease
- (2016) Paola Dongiovanni et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Epidemiology and natural history of non-alcoholic fatty liver disease
- (2016) Yousef Fazel et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
- (2016) Marialena Mouzaki et al. PLoS One
- Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
- (2015) Brian C. Ferslew et al. DIGESTIVE DISEASES AND SCIENCES
- Nonalcoholic Fatty Liver Disease
- (2015) Mary E. Rinella JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease
- (2015) Bratati Kahali et al. SEMINARS IN LIVER DISEASE
- The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
- (2015) Christopher Day et al. SEMINARS IN LIVER DISEASE
- Genetic background in nonalcoholic fatty liver disease: A comprehensive review
- (2015) Fabio Salvatore Macaluso WORLD JOURNAL OF GASTROENTEROLOGY
- Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
- (2015) Paola Dongiovanni et al. Biomed Research International
- Bile acids, obesity, and the metabolic syndrome
- (2014) Huijuan Ma et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Alcoholic and non-alcoholic steatohepatitis
- (2014) Manuela G. Neuman et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Beyond intestinal soap—bile acids in metabolic control
- (2014) Folkert Kuipers et al. Nature Reviews Endocrinology
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis
- (2013) Lars P. Bechmann et al. HEPATOLOGY
- Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
- (2012) Geoffrey Porez et al. JOURNAL OF LIPID RESEARCH
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
- (2011) Thijs W.H. Pols et al. Cell Metabolism
- Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis
- (2011) Srinivasan Dasarathy et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
- (2011) Zobair M. Younossi et al. HEPATOLOGY
- Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
- (2010) Luca Valenti et al. HEPATOLOGY
- Plasma metabolomic profile in nonalcoholic fatty liver disease
- (2010) Satish C. Kalhan et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Antiatherosclerotic effect of farnesoid X receptor
- (2008) Andrea Mencarelli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search